|
P3121
P3HT
P4
P41212
P450
P450 activity
P450 aromatase
P450 enzymes
P450 family
P450 genes
P450 isoforms
P450 monooxygenases
P450 oxidoreductase
P450 reductase
P450 system
P4 concentration
P4 level
P815 cells
P=
P=0.001
P=0.002
P=0.01
P=0.02
P=0.03
PA
PA6
PA6 phase
|
PA interventions
PA levels
PAA
PAC
PAC activity
PACAP receptor
PAF
PAF antagonists
PAF receptors
PAGE analysis
PAH
PAH concentrations
PAH contamination
PAH degradation
PAH levels
PAHs
PAI-1
PAI-1 activity
PAI-1 expression
PAI-1 gene
PAI-1 gene expression
PAI-1 gene polymorphisms
PAI-1 levels
PAI-1 mRNA
PAI-1 plasma levels
PAI-1 promoter
PAI-1 protein
PAI scores
|
PAL
PAL activity
PAL gain
PAM
PAMAM dendrimers
PAN
PAN fiber
PANI
PANI film
PANSS scores
PAP
PAPA syndrome
PAPP-A
PAPP-A levels
PAR-1 activation
PAR-2 activation
PAR1 activation
PAR4 agonist
PARP
PARP cleavage
PARP inhibitors
PAS
PAS domain
PAS staining
PASI score
PATIENT PATHWAYS
PATIENTS AND METHODS
PBC
|
PBC patients
PBDE congeners
PBL
PBMC
PBMC cultures
PBMC proliferation
PBMCs
PBS
PBS solution
PBSC collection
PBSC transplantation
PBT
PBT/PS blend
PBT matrix
PC
PC-3
PC-3 cells
PC-3 prostate cancer cells
PC/ABS blend
PC/PE blend
PC12 cell line
PC12 cells
PC3 cells
PC3 prostate cancer cells
PC activity
PC cells
PC cluster
PC films
|
PC patients
PC program
PC scores
PC substrate
PCA
PCA analysis
PCA method
PCB
PCB congeners
PCB exposure
PCB levels
PCB mixture
PCBM
PCBs
PCC
PCD
PCI
PCI patients
PCL
PCL blocks
PCL chains
PCL film
PCL scaffolds
|
